WeVote
Log In

Bill

Bill

SB 1100

AN ACT PERMITTING STATE CLAIMS AGAINST PHARMACEUTICAL COMPANIES FOR DAMAGES CAUSED BY A VACCINATION OR MEDICINAL TREATMENT PROGRAM.

2025 Regular Session Introduced by Rob Sampson

Connecticut bill permits state lawsuits against pharmaceutical companies for alleged damages from state-authorized vaccination or treatment programs.

REF. TO JOINT COMM. ON Judiciary
#claimsbythestate #damages #immunization #pharmaceuticalmanufacturingcompanies
0
WeVote Research Nonpartisan
Bill Summary · SB 1100

Legislative bill overview

SB 1100 would allow Connecticut to file lawsuits against pharmaceutical companies for damages allegedly caused by state-authorized vaccination or medicinal treatment programs. The bill creates a legal pathway for the state government to recover costs or seek compensation for harm it claims resulted from vaccines or treatments the state promoted or mandated.

Why is this important

This bill addresses the question of state liability and pharmaceutical accountability in public health initiatives. It has implications for how states can seek recourse if they believe approved medical products caused unintended harms, and could influence vaccination program policies and pharmaceutical liability frameworks nationwide.

Potential points of contention

  • Existing liability protections: Federal law (the National Childhood Vaccine Injury Act) and other statutes already provide pharmaceutical companies with liability shields for approved vaccines. This bill's compatibility with federal preemption and existing legal frameworks is unclear.
  • Public health program viability: Pharmaceutical companies may be less willing to supply vaccines or treatments to states facing potential litigation, potentially affecting public health emergency response and program availability.
  • Definition ambiguity: The bill doesn't specify what constitutes "damages caused by" a treatment program, creating uncertainty about causation standards, whether approved uses qualify, and how to distinguish program-related harms from other factors.
  • Insurance and cost implications: Litigation costs and potential settlements could significantly increase state budgets and insurance premiums for public health initiatives.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.